- World Pharma News Home » Published News » Corporate
(a free service delivered by FeedBurner)
Bristol-Myers Squibb is joining the world community in providing immediate help for survivors of the massive earthquake that struck Haiti on January 12. The company has already shipped a large donati
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
In the face of the unprecedented earthquake that hit the island of Haiti, sanofi-aventis has committed 1 million Euros in financial aid to long-term reconstruction initiatives and the rehabilitation
read more »
1 Comment Add this link to... Bury
1 Comment Add this link to... Bury
Pfizer will extend its MAINTAIN™ (Medicines Assistance for Those who Are in Need) patient assistance program for an additional year, through December 31, 2010. In addition to the more than 70 Pfizer
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
GlaxoSmithKline Biologicals SA (GSK) and Intercell announced an agreement to form a strategic alliance to accelerate the development and commercialisation of needle-free, patch-based vaccines. The ag
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Abbott (NYSE: ABT) announced today a definitive agreement to acquire STARLIMS Technologies Ltd. (Nasdaq: LIMS), a leading provider of laboratory information management systems, for approximately $123
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced an exclusive global licensing agreement with The Rockefeller University (New York, NY) concerning a novel monoclonal antibody, targeting certain
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
AstraZeneca and Targacept, Inc. announced a collaboration and licence agreement for the global development and commercialisation of TC-5214, Targacept's late-stage investigational product for major
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Novartis has gained exclusive rights to two oral targeted investigational therapies for patients with a range of life-threatening blood disorders and cancers that currently do not have effective trea
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Today, Novartis officially inaugurated the US's first ever large-scale flu cell culture vaccine and adjuvant manufacturing facility in Holly Springs, North Carolina. The facility is a result of a pa
read more »
1 Comment Add this link to... Bury
1 Comment Add this link to... Bury
Merck KGaA announced plans to strengthen its global research and development (R&D) capabilities of its Merck Serono division by establishing a global R&D center in Beijing, China. Merck is planning t
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
